Efficacy of Anti-TNF Agents as Adjunctive Therapy for Knee Synovitis Refractory to Disease-Modifying Antirheumatic Drugs in Patients with Peripheral Spondyloarthritis [PDF]
G Sakellariou+4 more
openalex +1 more source
THU0174 Drug retention of tofacitinib versus biologic antirheumatic agents in rheumatoid arthritis: observational data from the swiss scqm registry [PDF]
Axel Finckh+12 more
openalex +1 more source
Perception of COVID-19 vaccines in rheumatology patients. [PDF]
Romero-Bogado L+16 more
europepmc +1 more source
A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers [PDF]
Bernard Ng, Adeline Chu, Myrna M. Khan
openalex +1 more source
Associations of Demographic, Lifestyle, and Clinical Factors With the Presence of Dupuytren Disease: Results from the Lifelines Cohort Study. [PDF]
Noordman MFN+3 more
europepmc +1 more source
Further Evidence for Influenza and Pneumococcal Vaccination in Patients Treated with Disease Modifying Antirheumatic Drugs and Anti-Tumor Necrosis Factor Agents [PDF]
Meliha C Kapetanovic
openalex +1 more source
Real-world use of biologic and targeted synthetic disease-modifying antirheumatic drugs in US patients with psoriatic arthritis: Persistence, patient characteristics associated with discontinuation, and dosing patterns. [PDF]
Merola JF+6 more
europepmc +1 more source
Relationship between biologic therapy and cytokine levels in patients with inflammatory arthritis. [PDF]
Zhang Z+5 more
europepmc +1 more source
Pharmacokinetics of Carfenil, an antirheumatic agent in patients with renal insufficiency.
Akira Okazaki
openalex +2 more sources